Capital expenditure · 2011–2025
Ligand Pharmaceuticals capital expenditure
$452,000−75.2% · FY2025
Ligand Pharmaceuticals (LGND) reported $452,000 in capital expenditure for fiscal 2025, −75.2% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $452,000 | −75.2% | Open → |
| FY20242024-12-31 | $1.8M | −48.3% | Open → |
| FY20232023-12-31 | $3.5M | −80.4% | Open → |
| FY20222022-12-31 | $17.9M | +104.6% | Open → |
| FY20212021-12-31 | $8.8M | +96.5% | Open → |
| FY20202020-12-31 | $4.5M | +74.6% | Open → |
| FY20192019-12-31 | $2.6M | +187.8% | Open → |
| FY20182018-12-31 | $887,000 | −58.9% | Open → |
| FY20172017-12-31 | $2.2M | +16.5% | Open → |
| FY20162016-12-31 | $1.9M | +1,889.2% | Open → |
| FY20152015-12-31 | $93,000 | +1,450.0% | Open → |
| FY20142014-12-31 | $6,000 | −98.4% | Open → |
| FY20132013-12-31 | $377,000 | −36.6% | Open → |
| FY20122012-12-31 | $595,000 | +662.8% | Open → |
| FY20112011-12-31 | $78,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +13.4%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000886163-26-000006 · February 27, 2026
{{cite web |title=Ligand Pharmaceuticals capital expenditure — 10-K (0000886163-26-000006) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.